Searchable abstracts of presentations at key conferences in endocrinology

ea0050p051 | Bone and Calcium | SFEBES2017

1,25-dihydroxyvitamin D deficiency in haemodialysis patients is corrected by vitamin D supplementation

Huish Sharon , Jenkinson Carl , Fletcher Simon , Dunn Janet , Hewison Martin , Bland Rosemary

Reduced renal synthesis of 1,25-dihydroxyvitamin D (1,25(OH)2D) from 25-hydroxyvitamin D (25OHD) in end stage renal disease (ESRD) results in low serum 1,25(OH)2D. This appears to be due to reduced renal cell function and elevated serum fibroblast growth factor 23 (FGF23). Treatment strategies have therefore focussed on 1,25(OH)2D or its synthetic analogues, alfacalcidol or paricalcitol. However this overlooks 25-hydroxyv...

ea0086oc1.4 | Bone and Calcium | SFEBES2022

Measurements of circulating conjugated and unconjugated vitamin D metabolites by enzyme hydrolysis combined with liquid chromatography mass spectrometry

Jenkinson Carl , Desai Reena , McLeod Malcolm , Wolf Mueller Jonathan , Hewison Martin , Handelsman David

Recent in-vitro studies have shown that vitamin D metabolites undergo conjugation reactions by sulfation and glucuronidation and may be important mechanisms for the inactivation, storage and excretion of analytes. However the circulating concentrations and clinical significance of phase II vitamin D conjugation is unclear as current analysis has almost exclusively been restricted to measuring their unconjugated metabolite forms. In this study we aimed to develop an analytical ...

ea0090p132 | Pituitary and Neuroendocrinology | ECE2023

Comparative Efficacy and Safety of Osilodrostat Vs Metyrapone for the Treatment of Cushing’s Syndrome – a Matching-Adjusted Indirect Treatment Comparison

Tyas Emma , Hickey Conor , Hemstock Matthew , Binowski Grzegorz , Rios Carl , Schmidt Fabian

Objectives: Endogenous Cushing’s Syndrome (CS) is a rare, chronic condition that results in high morbidity, caused by prolonged exposure to elevated levels of circulating free cortisol levels. Osilodrostat, a newly approved steroidogenesis inhibitor, has been shown to achieve fast and high rates of cortisol normalization, improving manifestations of hypercortisolism in patients with Cushing’s Disease (CD), a form of CS. We evaluated relative complete response (CR) ou...

ea0049oc6.4 | Diabetes therapy and complications | ECE2017

Copeptin and its association to cardiovascular dysfunction in type 2 diabetes

Chisalita Simona Ioana , Chong Lee Ti , Nystrom Fredrik , Ostgren Carl Johan , Lanne Toste

Background: We aim to test whether plasma copeptin (copeptin), the C-terminal fragment of vasopressin, has predictive value of cardiovascular events in patients with type 2 diabetes without previous cardiovascular disease who were treated in primary care.Methods: We measured copeptin in 697 patients who participated in the epidemiological study CARDIPP (Cardiovascular Risk Factors in Patients with Diabetes – a Prospective Study in Primary Care; Clin...

ea0044p67 | Clinical biochemistry | SFEBES2016

Three minute run time LC-MS/MS method for separation and quantifying 25-hydroxyvitamin D from C3-epimers

Jenkinson Carl , Bradbury James , Taylor Angela , He Shan , Viant Mark , Hewison Martin

Vitamin D exists as two forms; D3 (UV) and D2 (plant derived). Measuring the metabolite 25-hydroxyvitamin D (25OHD) is routinely applied in research and clinical laboratories to assess vitamin D status. The Institute of Medicine and Society for Endocrinology have previously set recommended vitamin D guidelines based on combined 25OHD3 and 25OHD2 serum concentrations. In order to achieve accurate quantitation of these metabolites, the respective C3 epimers must be separately qu...

ea0038p362 | Reproduction | SFEBES2015

Vitamin D metabolic profiling across pregnancy

Susarla Radhika , Jenkinson Carl , Tamblyn Jennifer , Keevil Brian , Chan Shiao-Yng , Kilby Mark , Hewison Martin

Vitamin D-deficiency during pregnancy has been associated with increased complications of pregnancy including a high risk of pre-eclampsia (PET). Current analysis of vitamin D ‘status’ is based exclusively on analysis of maternal serum 25-hydroxyvitamin D3 (25(OH)D3), the circulating precursor form of vitamin D. We hypothesised that comprehensive profiling of vitamin D metabolites may provide a more accurate determination of vitamin D function i...

ea0038p395 | Steroids | SFEBES2015

Vitamin D2 vs vitamin D3: effects of total and free 25-hydroxyvitamin D on immune cells in vivo

Hernandez Ivan , Chun Rene , Larner Dean , Jemkinson Carl , Jeffery Louisa , Adams John S , Hewison Martin

Vitamin D metabolites such as 25-hydroxyvitamin D (25D) circulate bound primarily to vitamin D binding protein (DBP). However, for most extra-renal tissues 25D uptake is independent of DBP, even though the ‘free’ 25D fraction is very small. DBP has a lower binding affinity for 25D2 compared to 25D3. We hypothesized that this would increase serum free 25D2, with possible variations in vitamin D function. Mice were placed on diets containing equal amounts (1000 IU/kg) ...

ea0038p413 | Steroids | SFEBES2015

Profiling of multiple vitamin D metabolites in a healthy human cohort by high-throughput liquid chromatography–tandem mass spectrometry analysis

Jenkinson Carl , Taylor Angela , Susarla Radhika , Tamblyn Jennifer , Hassan-Smith Zaki , Keevil Brian , Hewison Martin

Although a complex metabolic pathway for vitamin D exists, serum measurement of inactive 25-hydroxyvitamin D3 (25OHD3) continues to be the most common determinant of vitamin D ‘status’. However, several other metabolites contribute to the physiological role of vitamin D, notably the active form 1α,25-dihydroxyvitamin D (1α,25(OH)2D3), inactive 3-epi-25OHD3 and chiral 23R and 24R,25(OH)2D3 metabolites. Quantification of these additional metabolites could pro...

ea0032p336 | Developmental Endocrinology | ECE2013

Effects of pharmacological and genetic manipulation of glucocorticoids during early development of the zebrafish embryo

Wilson Kathryn , Matrone Gianfranco , Tucker Carl , Hadoke Patrick , Kenyon Christopher , Mullins John , Denvir Martin

Background: The effects of glucocorticoids (GC) on the developing zebrafish embryo (Zfe) are poorly characterised. We have assessed the effects of pharmacological and genetic manipulation of cortisol and glucocorticoid receptors (GR) on global development and stress response during the first 120 hpf.Methods: Cortisol production was modulated by inhibiting the enzyme 11b hydroxylase using morpholino gene knockdown (MO) or incubation in the drug metyrapone...

ea0021p233 | Growth and development | SFEBES2009

A novel dominant-negative Glial Cells Missing B (GCMB) mutation (Asn502His) is associated with autosomal dominant hypoparathyroidism and results in reduced transactivation activity

Bowl Michael , Mirzcuk Samantha , Fratter Carl , Cranston Treena , Allgrove Jeremy , Brain Caroline , Nesbit Andrew , Thakker Rajesh

Glial cells missing B (GCMB), which is the mammalian homologue of the Drosophila GCM gene, encodes a 506 amino acid parathyroid-specific transcription factor that contains: a DNA-binding domain (residues 21–174); a predicted nuclear localization signal (residues 176–193); an inhibitory domain (residues 258–347); and two transactivation domains (residues 174–263, and residues 428–506). To date only two different GCMB m...